Galleon Group

Cardiovascular Implant Company PECA Labs Names Three New Board Members

Retrieved on: 
Tuesday, July 18, 2023
Health, Medical Devices, Cardiology, Barings Bank, Partnership, University, Raj Rajaratnam, Galleon Group, Anil Kumar, and Rajat Gupta insider trading cases, Wall Street, HUP, Heart, PwC, Yale School of Medicine, Galleon Group, Hospital of the University of Pennsylvania, Publication, Investment, Physician, PECA, UBS, Cowen, Hospital, Medtech, Cowen Inc., Management

The new board members will help guide the company as it develops and commercializes cardiovascular implants based on its novel tunable polymeric material platform.

Key Points: 
  • The new board members will help guide the company as it develops and commercializes cardiovascular implants based on its novel tunable polymeric material platform.
  • Dr. Carpenter is also a serial entrepreneur, including founding Embrella Cardiovascular, which was acquired by Edwards Lifesciences.
  • Jeffery O’Donnell, Sr. brings to PECA Labs more than 25 years of board and chief executive experience at emerging medical device companies.
  • O’Donnell founded and served as CEO for Trice Medical, and before that Embrella Cardiovascular, which was acquired by Edwards Lifesciences.

WealthVest Discusses Economic Scenarios with Apollo's Torsten Slok

Retrieved on: 
Thursday, March 2, 2023
OECD, Equity, Head, IMF, Slok Air International, Marketing, Spotify, Housing, Policy, Bloomberg, Apple, Stitcher, Interview, Risk, Money, Environment, BMO, Growth, Galleon Group, Apollo, Research fellow, Human, Deutsche Bank, CNBC, Real estate

BOZEMAN, Mont., March 2, 2023 /PRNewswire-PRWeb/ -- During a recent interview with WealthVest, a financial services marketing and wholesaling firm, Torsten Slok, Partner, and Chief Economist at Apollo, outlined his thoughts on the potential for a no-landing economic scenario and a delayed recession.

Key Points: 
  • WealthVest podcast interview delves into various macroeconomic trends that could lead to a no-landing economic scenario.
  • BOZEMAN, Mont., March 2, 2023 /PRNewswire-PRWeb/ -- During a recent interview with WealthVest, a financial services marketing and wholesaling firm, Torsten Slok, Partner, and Chief Economist at Apollo, outlined his thoughts on the potential for a no-landing economic scenario and a delayed recession.
  • A frequent guest on CNBC, Bloomberg and other media outlets, Slok has published numerous journal articles and reviews on economic and policy analysis.
  • Or can be accessed by searching for WealthVest: The Weekly Bull & Bear on the Apple podcast app, Spotify and Stitcher, or directly at https://shows.acast.com/the-weekly-bull-and-bear/episodes/s8e4-interview... .

Accure Acne announces the appointment of Samuel Navarro to the Board

Retrieved on: 
Tuesday, June 21, 2022
UBS, Solution, Barings Bank, Industry, University, Investment, Needham, Galleon Group, Company, Elective surgery, LLC, Wharton School of the University of Pennsylvania, University of Texas at Austin, Research, Engineering, Raj Rajaratnam, Galleon Group, Anil Kumar, and Rajat Gupta insider trading cases, Cowen Inc., Dermatology, Stanford University, Needham & Company, Patient, Board, Board of directors, M&A, Multimedia, Acne, Pharmaceutical industry, Isotretinoin

BOULDER, Colo., June 21, 2022 /PRNewswire/ -- Accure Acne, Inc. announced today that Samuel E. Navarro has joined Accure Acne's Board of Directors.

Key Points: 
  • BOULDER, Colo., June 21, 2022 /PRNewswire/ -- Accure Acne, Inc. announced today that Samuel E. Navarro has joined Accure Acne's Board of Directors.
  • Accure Acne continues to focus on delivering a durable treatment for acne to patients and healthcare providers around the world.
  • Mr. Navarro brings more than 30 years of Board, Executive and Investment Banking experience advising emerging growth medical device firms.
  • Learn more about Accure and our commitment to acne: www.accureacne.com
    View original content to download multimedia: https://www.prnewswire.com/news-releases/accure-acne-announces-the-appoi...